Active Pharmaceutical Ingredient (API)
Bedaquiline Fumarate
Novel Anti-Tuberculosis Agent (Diarylquinoline)
The first drug in a new class ($\text{Diarylquinolines}$) approved for $\text{MDR-TB}$ in decades. It works by inhibiting the mycobacterial $\text{ATP}$ synthase, blocking the bacterium's energy source. It is essential for newer, shorter $\text{MDR-TB}$ treatment regimens.
Technical Profile
- Reference Code
- BED537
- CAS Number
- 716788-75-1
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Bedaquiline Fumarate as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||